Exclusive

Publication

Byline

Location

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherap... Read More


Clinical Trial: Patient Reported Outcome Measurement Within the Secured Access to Innovative Medicines for Children With cAncer (SACHA) Study

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738601) titled 'Patient Reported Outcome Measurement Within the Secured Access to Innovative Medicines for C... Read More


Clinical Trial: Assessment of Post-Operative Pain After Using Cryotherapy and Dexamethasone

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738302) titled 'Assessment of Post-Operative Pain After Using Cryotherapy and Dexamethasone' on July 26. Br... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety... Read More


Clinical Trial: Speed of Processing Training to Improve Cognitive Functioning and Driving Performance in Head and Neck Cancer Survivors

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740616) titled 'Speed of Processing Training to Improve Cognitive Functioning and Driving Performance in Hea... Read More


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Mo... Read More


Clinical Trial: Does Group Therapy Improve Resilience and Family Functioning Among Mothers of Children With Intellectual Disabilities?

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738289) titled 'Does Group Therapy Improve Resilience and Family Functioning Among Mothers of Children With ... Read More


Clinical Trial: Early Addiction Care Pathway After Acute Drug Intoxication in Emergency Departments

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738835) titled 'Early Addiction Care Pathway After Acute Drug Intoxication in Emergency Departments' on June... Read More


Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in... Read More


Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and e... Read More